BOSTON SCIENTIFIC CORPORATION Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
BOSTON SCIENTIFIC CORPORATION (BSX) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $15.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-17
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $15.00M, a 16.67% decline from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $18.00M, a 37.93% decline from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $29.00M, a 262.50% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $8.00M, a 52.94% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month as first filed |
|---|---|---|
| 2025-12-31 | $15.00M 10-K · filed 2026-02-17 | |
| 2024-12-31 | $18.00M 10-K · filed 2026-02-17 | |
| 2023-12-31 | $29.00M 10-K · filed 2026-02-17 | |
| 2022-12-31 | $8.00M 10-K · filed 2025-02-18 | |
| 2021-12-31 | $17.00M 10-K · filed 2024-02-20 | |
| 2020-12-31 | $15.00M 10-K · filed 2023-02-23 | |
| 2019-12-31 | $9.00M 10-K · filed 2022-02-23 | |
| 2018-12-31 | $3.00M 10-K · filed 2021-02-23 | |
| 2017-12-31 | $2.00M 10-K · filed 2020-02-25 | |
| 2016-12-31 | $2.00M 10-K · filed 2019-02-19 | |
| 2015-12-31 | $7.00M 10-K · filed 2018-02-20 | -$7.00M 10-K · filed 2016-02-24 |
| 2014-12-31 | $10.00M 10-K · filed 2017-02-23 | -$10.00M 10-K · filed 2015-02-25 |
| 2013-12-31 | -$31.00M 10-K · filed 2016-02-24 | |
| 2012-12-31 | -$4.00M 10-K · filed 2015-02-25 | |
| 2011-12-31 | -$15.00M 10-K · filed 2014-02-26 | |
| 2010-12-31 | -$13.00M 8-K · filed 2013-05-29 | $13.00M 10-K · filed 2011-02-17 |
| 2009-12-31 | -$20.00M 10-K · filed 2012-02-17 | $20.00M 10-K · filed 2011-02-17 |
| 2008-12-31 | $6.00M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |